Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. The company is headquartered in South Jordan, Utah.
| Revenue (TTM) | $292.25M |
| Gross Profit (TTM) | $149.52M |
| EBITDA | $11.77M |
| Operating Margin | -5.35% |
| Return on Equity | -118.10% |
| Return on Assets | -3.02% |
| Revenue/Share (TTM) | $4.06 |
| Book Value | $1.87 |
| Price-to-Book | 1.39 |
| Price-to-Sales (TTM) | 0.44 |
| EV/Revenue | 0.705 |
| EV/EBITDA | -4.96 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -12.70% |
| Shares Outstanding | $75.26M |
| Float | $60.01M |
| % Insiders | 5.38% |
| % Institutions | 70.92% |
Volatility is currently expanding
Health Catalyst NASDAQ: HCAT reported second-quarter 2026 revenue above the high end of its guidance range and adjusted EBITDA at the high end of its outlook, while outlining a strategic shift following the July 31 divestiture of its Vitalware and Med-Metrix businesses.
Company retires all credit facility debt; transaction reflects concentrating its technology on improving health system performance. SALT LAKE CITY, Aug. 6, 2026 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst" or the "Company," Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced it closed the sale of Vitalware, LLC, through which the Company conducted its Vitalware business, to Med-Metrix, LLC, a technology-enabled revenue cycle management company, on July 31, 2026.
SALT LAKE CITY, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today reported financial results for the quarter ended June 30, 2026. “We delivered a very productive second quarter, exceeding the high end of our revenue guidance and the midpoint of our adjusted EBITDA guidance," said Ben Albert, Chief Executive Officer of Health Catalyst.
SALT LAKE CITY, July 28, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst”, Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, will release its second quarter 2026 operating results on Thursday, August 6, 2026, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day.
SALT LAKE CITY, June 16, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that members of senior management will participate in the Truist Securities Healthcare Disruptors & Digital Health Conference, including a panel discussion titled “AI ROI in Healthcare: Real vs Hype Debate,” with Ben Albert, Chief Executive Officer, on Wednesday, June 24, 2026, at 3:30pm ET.
PARSIPPANY, N.J., June 4, 2026 /PRNewswire/ -- Med-Metrix, LLC ("Med-Metrix"), backed by Harvest Partners and A&M Capital Partners, today announced it has entered into a definitive agreement to acquire Vitalware, an industry-leading revenue workflow and analytics software business owned by Health Catalyst (NASDAQ: HCAT).
Health Catalyst today announced it has signed a definitive agreement to divest Vitalware, its mid-revenue cycle business, to Med-Metrix for $147 million.
Health Catalyst, Inc. (HCAT) Q1 2026 Earnings Call Transcript
SALT LAKE CITY, May 11, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today reported financial results for the quarter ended March 31, 2026. “We delivered solid first quarter results, with revenue and adjusted EBITDA exceeding expectations,” said Ben Albert, Chief Executive Officer of Health Catalyst.
SALT LAKE CITY, May 01, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, will release its first quarter 2026 operating results on Monday, May 11, 2026, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on HCAT and any ticker you trade — then tracks every position and per-strategy win rate.
